These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2887588)

  • 21. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D; Hill C; Lenderking W; Williams V; Morlock R
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the effect of two benzodiazepines in the treatment of anxious outpatients.
    de Figueiredo R; Franchini A; Martinho A; Hindmarch I
    Int Pharmacopsychiatry; 1981; 16(1):57-65. PubMed ID: 6117537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alprazolam and diazepam in the treatment of generalized anxiety.
    Elie R; Lamontagne Y
    J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a physician rating scale for investigation of antianxiety effects of drugs [proceedings].
    Free SM; Overall JE
    Psychopharmacol Bull; 1977 Apr; 13(2):8-11. PubMed ID: 16312
    [No Abstract]   [Full Text] [Related]  

  • 26. The psychosedative effect of chlordesmethyldiazepam on anxiety states in neurotic and psychotic inpatients.
    Paradiso L; Rapisarda V
    Clin Ther; 1980; 3(3):194-9. PubMed ID: 6109567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concordance between the PHQ-9 and the HSCL-20 in depressed primary care patients.
    Lee PW; Schulberg HC; Raue PJ; Kroenke K
    J Affect Disord; 2007 Apr; 99(1-3):139-45. PubMed ID: 17049999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract]   [Full Text] [Related]  

  • 30. Normative data for the Multidimensional Anxiety Scale for Children (MASC) in Swedish adolescents.
    Ivarsson T
    Nord J Psychiatry; 2006; 60(2):107-13. PubMed ID: 16635928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial.
    Meibach RC; Dunner D; Wilson LG; Ishiki D; Dager SR
    J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary evaluation of the anxiolytic activity of clobazam.
    Sandler K; Brunswick D; Digiacomo J; Mendels J
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):114-6. PubMed ID: 12920
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding the use of behavioral rating scales in studies evaluating the efficacy of antianxiety and antidepressant drugs.
    Fankhauser MP; German ML
    Am J Hosp Pharm; 1987 Sep; 44(9):2087-100. PubMed ID: 2890299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1988 May; 49(5):189-92. PubMed ID: 2896666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot open-label study on U-31,889 in anxious in-patients.
    Fabre LF; Harris RT
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1010-3. PubMed ID: 4154181
    [No Abstract]   [Full Text] [Related]  

  • 37. Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression.
    Dunner D; Myers J; Khan A; Avery D; Ishiki D; Pyke R
    J Clin Psychopharmacol; 1987 Jun; 7(3):170-2. PubMed ID: 3298327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalized anxiety disorder in older adults: examining the relation between clinician severity ratings and patient self-report measures.
    Hopko DR; Bourland SL; Stanley MA; Beck JG; Novy DM; Averill PM; Swann AC
    Depress Anxiety; 2000; 12(4):217-25. PubMed ID: 11195758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical methodology for testing of anxiolytic drugs.
    Bourin M
    Therapie; 2000; 55(1):147-53. PubMed ID: 10860018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician Withdrawal Checklist (PWC-20).
    Rickels K; Garcia-Espana F; Mandos LA; Case GW
    J Clin Psychopharmacol; 2008 Aug; 28(4):447-51. PubMed ID: 18626273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.